Your browser doesn't support javascript.
loading
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients.
Zom, Gijs G; Welters, Marij J P; Loof, Nikki M; Goedemans, Renske; Lougheed, Sinéad; Valentijn, Rob R P M; Zandvliet, Maarten L; Meeuwenoord, Nico J; Melief, Cornelis J M; de Gruijl, Tanja D; Van der Marel, Gijsbert A; Filippov, Dmitri V; Ossendorp, Ferry; Van der Burg, Sjoerd H.
Afiliação
  • Zom GG; Department of Immunohematology and Blood Transfusion, Section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands.
  • Welters MJ; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Loof NM; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Goedemans R; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Lougheed S; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Valentijn RR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Zandvliet ML; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Meeuwenoord NJ; Leiden Institute of Chemistry, University of Leiden, Leiden, The Netherlands.
  • Melief CJ; Department of Immunohematology and Blood Transfusion, Section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Gruijl TD; ISA Pharmaceuticals BV, Leiden, The Netherlands.
  • Van der Marel GA; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Filippov DV; Leiden Institute of Chemistry, University of Leiden, Leiden, The Netherlands.
  • Ossendorp F; Leiden Institute of Chemistry, University of Leiden, Leiden, The Netherlands.
  • Van der Burg SH; Department of Immunohematology and Blood Transfusion, Section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands.
Oncotarget ; 7(41): 67087-67100, 2016 Oct 11.
Article em En | MEDLINE | ID: mdl-27564262
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Linfócitos T / Neoplasias do Colo do Útero / Proteínas Oncogênicas Virais / Adjuvantes Imunológicos / Vacinas Anticâncer Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Linfócitos T / Neoplasias do Colo do Útero / Proteínas Oncogênicas Virais / Adjuvantes Imunológicos / Vacinas Anticâncer Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article